This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Asia-Pacific Beiotech Developing, Inc., Asia-Pacific Biotech Developing, Inc., National Sun Yat-Sen University of Kaohsiung. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: Fu-Hsin Chang: Innovator in Cancer Treatment
Introduction
Fu-Hsin Chang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 3 patents, Chang's work focuses on utilizing lycogen extracts to inhibit cancer metastasis.
Latest Patents
Chang's latest patents include a method for adjunctive treatment of cancer metastasis using a Lycogen composition. This invention involves administering a Lycogen composition to a subject, which contains an effective amount of a Lycogen extract. The active ingredients in this extract include β-carotene, neurosporene, spheroidenone, and methoxyneurosporene. Another patent describes a lycogen extract that comprises these active ingredients and a composition that includes a food scientific or pharmaceutical acceptable carrier. This method aims to provide therapeutic benefits to patients in need of treatment.
Career Highlights
Throughout his career, Fu-Hsin Chang has worked with various companies, including Asia-Pacific Biotech Developing, Inc. His experience in the biotech industry has allowed him to develop innovative solutions for cancer treatment.
Collaborations
Chang has collaborated with notable coworkers such as Wen-Sheng Liu and Ya-Wen Tsai. Their combined expertise has contributed to the advancement of his research and inventions.
Conclusion
Fu-Hsin Chang's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work with lycogen extracts represents a promising avenue in the fight against cancer metastasis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile